TARSUS PHARMACEUTICALS, INC. (TARS)
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
Immunocore reports second quarter financial results and provides a business update
Viridian Therapeutics, Inc. - Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
Safe Pro Group Receives $780,000 Purchase Order for Department of War Package of Edge AI-Powered Threat Mapping and Blue UAS Drones
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Zoetis - Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer
Compass Pathways - Compass Pathways to Participate in Canaccord Genuitys 46th Annual Growth Conference on August 12, 2026
Zoetis - Zoetis Announces Second Quarter 2026 Results
Sharon AI Reports Second Quarter 2026 Results
KVH Industries Reports Second Quarter 2026 Results
Federal Realty Announces Proposed Private Placement of $400 Million of Exchangeable Senior Notes